CorMedix Inc.

CRMD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001410098

SEC filings (opens in a new tab)

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding CorMedix Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of CRMD: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	79	79	0
Shares	10.8M	11.4M	+580.0K (+5.4%)
Value	$107.6M	$78.0M	−$29.7M (−27.6%)

New holders (10)

Institutions that held CorMedix Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CRMD in Q2 2021
Institution	Shares	Value	% of portfolio
Two Sigma Investments, LP	198,700	$1.36M	0.00%
Qube Research & Technologies Ltd	28,771	$197.0K	0.00%
State of Wisconsin Investment Board	26,600	$182.0K	0.00%
ExodusPoint Capital Management, LP	21,310	$146.0K	0.00%
Cambridge Investment Research Advisors, Inc.	18,700	$128.0K	0.00%
National Asset Management, Inc.	11,850	$108.0K	0.00%
Virtu Financial LLC	15,180	$104.0K	0.01%
Man Group plc	13,100	$90.0K	0.00%
AdvisorNet Financial, Inc	1,329	$9.00K	0.00%
BDO Wealth Advisors, LLC	450	$3.00K	0.00%

Sold out (10)

Institutions that held CorMedix Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CRMD in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Maven Securities LTD	111,065	$1.08M
California Public Employees Retirement System	52,200	$521.0K
Wealthstreet Investment Advisors, LLC	31,200	$312.0K
Squarepoint Ops LLC	22,275	$223.0K
Two Sigma Securities, LLC	10,840	$108.0K
Meeder Asset Management Inc	2,144	$21.0K
Bank of Montreal	1,261	$12.0K
Jacobi Capital Management LLC	500	$5.00K
PrairieView Partners, LLC	400	$4.00K
Retirement Group, LLC	399	$4.00K